论文部分内容阅读
目的对法舒地尔治疗椎基底动脉供血不足性眩晕的疗效进行临床观察。方法采用随机对照方法,治疗组予法舒地尔针30mg,加入盐酸培他啶注射液500m1中静滴,1次/d;对照组予丁咯地尔针150mg,加入盐酸培他啶注射液500m1中静滴,1次/d。疗程为14d。2组针对部分特殊病例高血糖、高血压等情况对症治疗。结果经治疗,治疗组显效率84.0%,好转率12.0%,总有效率达96.0%,显效率优于对照组(P<0.05),总有效率差异无显著性(P>0.05)。治疗中未出现任何不良反应。结论法舒地尔治疗椎基底动脉供血不足性眩晕效果确切,安全可靠,值得推广。
Objective To observe the efficacy of fasudil in the treatment of Vertebrobasilar insufficiency vertigo. Methods A randomized controlled trial was conducted. The patients in the treatment group were given Fasudil 30 mg and treated with intravenous infusion of pertitadine hydrochloride 500 m 1 once a day. The control group was given Buflomedil 150 mg, 500m1 intravenous infusion, 1 time / d. Treatment for 14d. 2 groups for some special cases of hyperglycemia, hypertension and other symptomatic treatment. Results After treatment, the effective rate was 84.0%, the improvement rate was 12.0% and the total effective rate was 96.0% in the treatment group. The effective rate of the treatment group was better than that of the control group (P <0.05). There was no significant difference in the total effective rate (P> 0.05). No adverse reactions to treatment. Conclusion fasudil treatment vertebrobasilar insufficiency vertigo effect is accurate, safe and reliable, it is worth promoting.